Glenview Trust CO Dexcom Inc Transaction History

Glenview Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $177,726 - $217,995	1,556 New	1,556 $215,000
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $337 - $392	-3 Reduced 0.14%	2,087 $268,000
Q1 2023 May 09, 2023	BUY	$104.0 - $122.92 $1,664 - $1,966	16 Added 0.77%	2,090 $242,000
Q4 2022 Feb 08, 2023	BUY	$84.98 - $122.67 $176,248 - $254,417	2,074 New	2,074 $234,000

1,113

365M

4.1M

3.65M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $25.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Glenview Trust CO, based on Form 13F filings with the SEC.

Stay updated on Glenview Trust CO with notifications on news.